Federal Register Notice: FDA’s Pulmonary-Allergy Drugs Advisory Committee will meet 9/5, from 8 a.m. to 5:30 p.m. at the Holiday Inn, Gaithersburg, MD. The committee will discuss an NDA for Ariflo (cilomilast) tablets, 15 mg, by GlaxoSmithKline, for use in chronic obstructive pulmonary disease. Contact Kimberly Littleton Topper, (301) 827-7001. To view this notice, click here.
